GlassScriptPhysician profile
Nnaemeka Chikwendu
NPI 1841399656
$1,342.07
in general payments reported to CMS, 2019-2025
12 companies · $993 in 2025
The $993 reported for 2025 was more than what 78% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.26 · 2022: $61.12 · 2023: $15.28 · 2024: $228 · 2025: $993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,235.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $527.03 | 2024-2025 | Ellipsys Vascular Access System |
| Tactile Systems Technology INC | $295.54 | 2025 | Flexitouch Plus, Nimbl |
| W. L. Gore & Associates, INC. | $119.95 | 2021-2025 | Gore Viabahn Endoprosthesis |
| Edwards Lifesciences Corporation | $90.16 | 2025 | |
| Inari Medical, INC. | $79.09 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Angiodynamics, INC. | $61.12 | 2022 | |
| Bard Peripheral Vascular, INC. | $47.51 | 2023-2025 | Covera |
| Medline Industries LP | $30.61 | 2024 | |
| Lemaitre Vascular, INC. | $30.18 | 2024 | Artegraft Vascular Graft |
| Cardiovascular Systems INC. | $23.91 | 2021 | |
| Abbott Laboratories | $23.46 | 2024 | Perclose Prostyle |
| Globus Medical, INC. | $13.51 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nnaemeka Chikwendu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.